ACLX
Price
$63.61
Change
+$0.49 (+0.78%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
3.48B
14 days until earnings call
ROIV
Price
$10.73
Change
+$0.31 (+2.98%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
7.66B
62 days until earnings call
Ad is loading...

ACLX vs ROIV

Header iconACLX vs ROIV Comparison
Open Charts ACLX vs ROIVBanner chart's image
Arcellx
Price$63.61
Change+$0.49 (+0.78%)
Volume$9.34K
Capitalization3.48B
Roivant Sciences
Price$10.73
Change+$0.31 (+2.98%)
Volume$155.95K
Capitalization7.66B
ACLX vs ROIV Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. ROIV commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a StrongBuy and ROIV is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ACLX: $63.12 vs. ROIV: $10.42)
Brand notoriety: ACLX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 47% vs. ROIV: 93%
Market capitalization -- ACLX: $3.48B vs. ROIV: $7.66B
ACLX [@Biotechnology] is valued at $3.48B. ROIV’s [@Biotechnology] market capitalization is $7.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 6 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 5 bearish.
  • ROIV’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +2.75% price change this week, while ROIV (@Biotechnology) price change was +3.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.67%. For the same industry, the average monthly price growth was -9.26%, and the average quarterly price growth was -12.98%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.66B) has a higher market cap than ACLX($3.48B). ROIV YTD gains are higher at: -11.919 vs. ACLX (-17.695). ROIV has higher annual earnings (EBITDA): 4.1B vs. ACLX (-99.06M). ROIV has more cash in the bank: 5.15B vs. ACLX (587M). ACLX has less debt than ROIV: ACLX (54.1M) vs ROIV (100M). ROIV has higher revenues than ACLX: ROIV (123M) vs ACLX (108M).
ACLXROIVACLX / ROIV
Capitalization3.48B7.66B45%
EBITDA-99.06M4.1B-2%
Gain YTD-17.695-11.919148%
P/E RatioN/A1.97-
Revenue108M123M88%
Total Cash587M5.15B11%
Total Debt54.1M100M54%
TECHNICAL ANALYSIS
Technical Analysis
ACLXROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 16 days ago
78%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WEBL15.441.32
+9.35%
Direxion Daily Dow Jones Int Bl 3X ETF
BUFG22.880.39
+1.74%
FT Vest Buffered Allocation Gr ETF
DMXF67.471.05
+1.58%
iShares ESG Advanced MSCI EAFE ETF
FLSA34.810.38
+1.10%
Franklin FTSE Saudi Arabia ETF
SRLN40.420.04
+0.10%
SPDR® Blackstone Senior Loan ETF

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RCKT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+3.59%
RCKT - ACLX
56%
Loosely correlated
-2.79%
DNLI - ACLX
55%
Loosely correlated
+11.03%
KRYS - ACLX
55%
Loosely correlated
+4.26%
ROIV - ACLX
54%
Loosely correlated
+3.78%
RNA - ACLX
52%
Loosely correlated
+3.26%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+3.78%
IMVT - ROIV
59%
Loosely correlated
-1.45%
ACLX - ROIV
54%
Loosely correlated
+3.59%
RCKT - ROIV
50%
Loosely correlated
-2.79%
DYN - ROIV
49%
Loosely correlated
+6.22%
KRYS - ROIV
49%
Loosely correlated
+4.26%
More